Testing effectiveness (Phase 2)Study completedNCT02513095
What this trial is testing
Efficacy and Safety of Ryanodex® (EGL-4104) as Adjuvant Treatment in Subjects With Exertional Heat Stroke (EHS)
Who this might be right for
Heat Stroke
Eagle Pharmaceuticals, Inc. 34